Hepatitis C virus serology in parenteral drug users with chronic liver disease

Addiction

Volumn 92, Issue 2, 1997, Pages 167-171

  Novick, David M ^a,b,e   Reagan, Kevin J ^c,d   Croxson, T Scott ^b   Gelb, Alvin M ^b   Stenger, Richard J ^b   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c Ortho McNeil Pharmaceutical Incorporated   (United States)

^d Specialty Laboratories   (United States)

^e Digestive Specialists Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ALCOHOL ABUSE; ARTICLE; CHRONIC LIVER DISEASE; DRUG ABUSE; DRUG DEPENDENCE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE;

ADULT; ALCOHOLISM; CHRONIC DISEASE; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER CIRRHOSIS; MALE; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0031051962     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1360-0443.1997.tb03649.x     Document Type: Article

References (35)

1. ALBERTI, A. (1991) Diagnosis of hepatitis C: facts and perspectives, Journal of Hepatology, 12, 279-282.
2. ALTER, M. (1991) Epidemiology of community-acquired hepatitis C, in: HOLLINGER, F. B., LEMON, S. M. & MARGOLIS, H. S. (Eds) Viral Hepatitis and Liver Disease, pp. 410-413 (Baltimore, Williams and Wilkins).
3. BRECHOT, C. (1993) Polymerase chain reaction for the diagnosis of viral hepatitis B and C, Gut, 34 (suppl), S39-S44.
4. BRILLANTI, S., MASCI, C., SIRINGO, S., Di FEBO, G., MIGLIOLI M. & BARBARA, L. (1991) Serological and histological aspects of hepatitis C virus infection in alcoholic patients, Journal of Hepatology, 13, 347-350.
5. BROWN, J., DOURAKIS, S., KARAYIANNIS, P. et al. (1992) Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic liver disease, Hepatology, 15, 175-179.
6. CALDWELL, S. H., LI, X., ROURK, R. M., et al. (1993) Hepatitis C infection by polymerase chain reaction in alcoholics: false-positive ELISA results and the influence of infection on a clinical prognostic score, American Journal of Gastroenterology, 88, 1016-1021.
7. DES JARLAIS, D. C., FRIEDMAN, S. R., NOVICK, D. M. et al. (1989) HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987, Journal of the American Medical Association, 261, 1008-1012.
8. DONAHUE, J. G., NELSON, K. E., MUNOZ, A. et al. (1991) Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland, American Journal of Epidemiology, 134, 1206-1211.
9. DUSHEIKO, G. & SIMMONDS, P. (1994) Sequence variability of hepatitis C virus and its clinical relevance, Journal of Viral Hepatitis, 1, 3-15.
10. ESTEBAN, J. I., ESTEBAN, R., VILADOMIU, L. et al. (1989) Hepatitis C virus antibodies among risk groups in Spain, Lancet, 2, 294-296.
11. FARCI, P., ALTER, H. J., GOVINDARAJAN, S. et al. (1992) Lack of protective immunity against reinfection with hepatitis C virus, Science, 258, 135-140.
12. FONG, T-L., KANEL, G. C., CONRAD, A., VALINLUCK, B., CHARBONEAU, F. & ADKINS, R. H. (1994) Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease, Hepatology, 19, 554-557.
13. GELB, A. M., RICHMAN, B. L. & ANAND, D. P. (1978) Quantitative and temporal relationships of alcohol use in narcotic addicts and methadone maintenance patients undergoing alcohol detoxification, American Journal of Drug and Alcohol Abuse, 5, 191-198.
14. KELEN, G. D., GREEN, G. B., PURCELL, R. H. et al. (1992) Hepatitis B and hepatitis C in emergency department patients, New England Journal of Medicine, 326, 1399-1404.
15. KOFF, R. S. & DIENSTAG, J. L. (1995) Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease, Seminars in Liver Disease, 15, 101-109.
16. KREEK, M. J. (1978) Medical complications in methadone patients, Annals of the New York Academy of Science, 311, 110-134.
17. KREEK, M. J., DES JARLAIS, D. D., TREPO, C. L., NOVICK, D.M., ABDUL-QUADER A. & RAGHUNATH J. (1990) Contrasting prevalence of delta hepatitis in parenteral drug abusers with and without AIDS, Journal of Infectious Disease, 162, 538-541.
18. KREEK, M. J., DODES, L., RANE, S., KNOBLER, J. & MARTIN, R. (1972) Long-term methadone maintenance therapy: effects on liver function, Annals of Internal Medicine, 77, 598-602.
19. MCFARLANE, I. G. (1993) Hepatitis C and alcoholic liver disease, American Journal of Gastroenterology, 88, 982-988.
20. MENDENHALL, C. L., MORITZ, M. S., ROUSTER, S. et al. & VA COOPERATIVE STUDY GROUP 275 (1993) Epidemiology of hepatitis C among Veterans with alcoholic liver disease, American Journal of Gastroenterology, 88, 1022-1026.
21. NOVICK, D. M. (1992) The medically ill substance abuser, in: LOWINSON, J. H., RUIZ, P., MILLMAN R. B. & LANGROD, J. G. (Eds) Substance Abuse: a comprehensive textbook, pp. 657-674 (Baltimore, Williams and Wilkins).
22. NOVICK, D. M., GELB, A. M., STENGER, R. J. et al. (1981) Hepatitis B serologic studies in narcotic users with chronic liver disease, American Journal of Gastroenterology, 75, 111-115.
23. NOVICK, D. M., ENLOW, R. W., GELB, A. M. et al. (1985a) Hepatic cirrhosis in young adults: association with adolescent onset of alcohol and parenteral heroin abuse, Gut, 26, 8-13.
24. NOVICK, D. M., FARCI, P., KARAYIANNIS, P. et al. (1985b) Hepatitis D virus antibody in HBsAg-positive and HBsAg-negative substance abusers with chronic liver disease, Journal of Medical Virology, 15, 351-356.
25. NOVICK, D. M., STENGER, R. J., GELB, A. M., MOST, J., YANCOVITZ, S. R. & KREEK, M. J. (1986) Chronic liver disease in abusers of alcohol and parenteral drugs; a report of 204 consecutive biopsy-proven cases, Alcoholism: Clinical and Experimental Research, 10, 500-505.
26. NOVICK, D. M., FARCI, P., CROXSON, T. S. et al. (1988) Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive, Journal of Infectious Diseases, 158, 759-803.
27. NOVICK, D. M., JOSEPH, H., CROXSON, T. S. et al. (1990) Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients, Archives of Internal Medicine, 150, 97-99.
28. OSHITA, M., HAYASHI, N., KASAHARA, A. et al. (1994). Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C, Hepatology, 20, 1115-1120.
29. OSMOND, D. H., PADIAN, N. S., SHEPPARD, H. W., GLASS, S., SHIBOSKI, S. C. & REINGOLD, A. (1993) Risk factors for hepatitis C virus serpositivity in heterosexual couples, Journal of the American Medical Association, 269, 361-365.
30. RALL, C. J. N. & DIENSTAG, J. L. (1995) Epidemiology of hepatitis C virus infection, Seminars in Gastrointestinal Disease, 6, 3-12.
31. SEEFF, L. B., BUSKELL-BALES, Z., WRIGHT, E. C. et al. & NATIONAL HEART, LUNG AND BLOOD INSTITUTE STUDY GROUP (1992) Long-term mortality after transfusion-associated non-A, non-B hepatitis, New England Journal of Medicine, 327, 1906-1911.
32. SHERLOCK, S. (1994) Chronic hepatitis C, Disease-a-month, 40, 122-196.
33. STENGER, R. J. (1984) Interpretation of Liver Biopsies (New York, Raven Press).
34. WOODFIELD, D. G., HARNESS, M. & RIX-TROTT, R. (1993) Hepatitis C virus infections in oral and injectable drug users, New Zealand Journal of Medicine, 106, 332-334.
35. YANO, M., YATSUHASHI, H., INOUE, O., INOKICHI, K. & KOGA, M. (1993) Epidemiology and long term prognosis of hepatitis C virus infection in Japan, Gut, 34 (suppl), S13-S16.